Biotech Archives - Page 36 of 61 - Life Sciences Times

European Commission Approves Alnylam’s AMVUTTRA for ATTR Amyloidosis with Cardiomyopathy

June 9, 2025

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

June 7, 2025

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

THIS WEEK'S STORIES

Agenus and Zydus Lifesciences Sign $141 Million Deal to Advance Cancer Immunotherapy and Expand U.S. Biologics Manufacturing

June 3, 2025

Rad AI Appoints Demetri Giannikopoulos as Chief Growth Officer to Expand AI Footprint in U.S. Radiology

June 2, 2025

European Commission Approves Alnylam’s AMVUTTRA for ATTR Amyloidosis with Cardiomyopathy

June 9, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

IonQ, AstraZeneca, AWS, and NVIDIA Achieve 20x Speedup in Quantum-Accelerated Drug Development Workflow

Phare Bio Chosen for Google.org Accelerator to Advance Open-Access AI Antibiotic Discovery Platform

IDEXX Launches In-Clinic Cortisol Test to Help Veterinarians Diagnose Canine Endocrine Disorders

Bruker Showcases Next-Generation Mass Spectrometry Innovations at ASMS 2025

FDA Grants Platform Technology Designation to Sarepta’s Viral Vector Used in SRP-9003 Gene Therapy

Most Read

Wolters Kluwer Enhances Sentri7 to Streamline Pharmacy and Nursing Workflows

Agiliti Launches NP Line of Stretcher Support Surfaces to Improve Patient Comfort and Infection Control

Phillips Medisize Unveils TheraVolt Medical Connectors to Advance Device Integration and Performance

IonQ, AstraZeneca, AWS, and NVIDIA Achieve 20x Speedup in Quantum-Accelerated Drug Development Workflow

EDITOR PICKS

European Commission Approves Alnylam’s AMVUTTRA for ATTR Amyloidosis with Cardiomyopathy

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

THIS WEEK'S STORIES

Agenus and Zydus Lifesciences Sign $141 Million Deal to Advance Cancer Immunotherapy and Expand U.S. Biologics Manufacturing

Rad AI Appoints Demetri Giannikopoulos as Chief Growth Officer to Expand AI Footprint in U.S. Radiology

European Commission Approves Alnylam’s AMVUTTRA for ATTR Amyloidosis with Cardiomyopathy

POPULAR CATEGORY

ABOUT US

FOLLOW US